Customer References

“The Definiens Enterprise Image Intelligence Suite is an open platform that can be easily integrated with the existing hardware as well as image acquisition devices and software. It enables even untrained users to calibrate and execute versatile image analysis workflows [...]”

Dr. Markus Mandler, Head of Neurodegeneration Department at Affiris

“Definiens’ technology underpins ALTANA’s move towards integrated image assessment which will advance even further now that ALTANA belongs to the new NYCOMED organization.”

Prof. Germann, Head of IPAS (Institut für Präklinische Arzneimittelsicherheit)

"We are using Definiens Developer to analyze fluorescently stained images. The Thumbnail View and the Swipe View  that come with version 7 have been saving us a lot of time. The new pre-processing algorithms and pixelfilters enable us to process pixellayers upfront. This means that we can identify the relevant structures easier and faster."

Dr. Jo Peel, Senior Scientist, AstraZeneca

“After we tested and reviewed the available high content screening software, it became obvious that there is no other solution out there that can support us in the extremely challenging image analysis tasks we perform for our customers.”

Dr. Michael Hannus, Group Leader, Cell-based Discovery & Validation, Cenix BioScience

"Image analysis is frequently a bottleneck when evaluation morphological endpoints in cellular assays. Using Definiens automated process the time to completion of analysis is significantly reduced, coupled with a significant increase in objectivity. Definiens’ technology is now integral in the analysis of the growth cone collapse assay at GlaxoSmithKline."

Dr. Elena Di Daniel, Senior Scientist,
GlaxoSmithKline

“Definiens has opened up new worlds of opportunities for performing screens utilizing assays that have previously been impossible to accommodate in high throughput screens due to the lack of refined software for automated image analysis and data extraction.”

Dr. Ivan Baines, Scientific Coordinator and Director of Services and Facilities at MPI-CBG

“Definiens solutions will play a decisive role in MRI continuous efforts for the development of new services in biological imaging."

Dr. Pierre Travo, Chief Manager at Montpellier RIO Imaging

“Definiens solved our problem of automatically detecting small intestine crypts and counting proliferating and non-proliferating cells which was not possible with any other software solution.”

Dr. Elke Persohn, Head of the Cellular Imaging Group, at Novartis Pharma AG 

"To assess the islet structure and function, quantitative analysis of islet morphology using customized islet image analysis software developed by Definiens AG and in situ pancreas perfusion were performed..."

Dr. Sabine Uhles, Hoffmann-La Roche

“In order to put molecular histopathology at the core of Servier’s drug discovery programs, the decision to integrate Definiens’ innovative and robust Definiens Enterprise Image Intelligence™ Suite is a critical step in the success of this strategy.”

Brian Lockhart, Director Molecular Pharmacology and Pathophysiology at Servier